v3.25.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Redeemable Convertible Preferred Stock
Preferred Stock
Common Stock
Related Party Promissory Note
Additional Paid-in Capital
Accumulated deficit
Total
Balance at Dec. 31, 2022 $ 5,466,925 $ 76 $ 2,065,542 $ (11,784,387) $ (9,718,769)
Balance (in Shares) at Dec. 31, 2022 13,661,416 758,967        
Cash contribution from stockholder 8,711,966 8,711,966
Assumption of promissory notes and related accrued interest by stockholder 5,426,120 5,426,120
Stock-based compensation 5,428 5,428
Reimbursement of equity issuance cost to stockholder (5,802)   (5,802)
Net loss (9,941,284) (9,941,284)
Balance at Dec. 31, 2023 $ 5,466,925 $ 76 16,203,254 (21,725,671) (5,522,341)
Balance (in Shares) at Dec. 31, 2023 13,661,416 758,967        
Stock-based compensation 20,422 20,422
Stock-based compensation (in Shares)        
Net loss (151,677) (151,677)
Balance at Mar. 31, 2024 $ 5,466,925 $ 76 16,223,676 (21,877,348) (5,653,596)
Balance (in Shares) at Mar. 31, 2024 13,661,416 758,967        
Balance at Dec. 31, 2023 $ 5,466,925 $ 76 16,203,254 (21,725,671) (5,522,341)
Balance (in Shares) at Dec. 31, 2023 13,661,416 758,967        
Cash contribution from stockholder 7,450,000 7,450,000
Distribution of SAFE instruments upon conversion of capital contribution (4,312,496) (4,312,496)
Issuance of note receivable to stockholder and related accrued interest (4,065,096) (4,065,096)
Stock-based compensation 472,263 472,263
Issuance of common stock, net of issuance cost $ 824 28,706,815 28,707,639
Issuance of common stock, net of issuance cost (in Shares) 8,241,375        
Issuance of common stock upon conversion of convertible preferred shares $ (5,466,925) $ 1,366 5,465,559 5,466,925
Issuance of common stock upon conversion of convertible preferred shares (in Shares) (13,661,416) 13,661,416        
Issuance of common stock upon conversion of SAFE instruments $ 316 12,645,508 12,645,824
Issuance of common stock upon conversion of SAFE instruments (in Shares) 3,161,456        
Issuance of shares of common stock of the continuing company to Venetian shareholders $ 138 (138)
Issuance of shares of common stock of the continuing company to Venetian shareholders (in Shares) 1,375,000        
Net loss (17,087,453) (17,087,453)
Balance at Dec. 31, 2024 $ 2,720 (4,065,096) 66,630,765 (38,813,124) 23,755,265
Balance (in Shares) at Dec. 31, 2024 27,198,214        
Stock-based compensation 611,502 611,502
Issuance of common stock, net of issuance cost $ 2,000 18,492,000 18,494,000
Issuance of common stock, net of issuance cost (in Shares) 5,000,000        
Interest receivable on promissory note issued to stockholder (59,178) (59,178)
Net loss (6,202,164) (6,202,164)
Balance at Mar. 31, 2025 $ 4,720 $ (4,124,274) $ 85,734,267 $ (45,015,288) $ 36,599,425
Balance (in Shares) at Mar. 31, 2025 32,198,214